Autoimmunity, Part D
Autoimmune Disease, Annus Mirabilis, Volume 1108
Herausgeber: Bragazzi, Nicola Luigi; Gershwin, M Eric
Autoimmunity, Part D
Autoimmune Disease, Annus Mirabilis, Volume 1108
Herausgeber: Bragazzi, Nicola Luigi; Gershwin, M Eric
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The incidence of autoimmune diseases is increasing worldwide, and the search for better management of these diseases and even for a cure is being pursued by scientists from many disciplines. Tools from the areas of genetics, neuroscience, cell biology, virology, and infectious disease are being applied to the problem and are yielding useful results. This is the fourth and final volume of a series on autoimmunity, and findings related to particular clinical manifestations are presented, particularly systemic lupus erythematosus, scleroderma, rheumatoid arthritis, Sjogren's syndrome,…mehr
- SHOENFELDAutoimmunity, Part a194,99 €
- Yehuda ShoenfeldAutoimmune Diseases and Treatment202,99 €
- The Year in Immunology 2008, Volume 1143194,99 €
- Ralph SteinmanHuman Immunology183,99 €
- David TerferaClinical Anatomy for Dummies31,99 €
- Peter J GoslingDictionary of Parasitology87,99 €
- Neil R BorleyInstant Physiology49,99 €
-
-
-
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Wiley
- Seitenzahl: 628
- Erscheinungstermin: 1. Januar 2008
- Englisch
- Abmessung: 229mm x 161mm x 25mm
- Gewicht: 1048g
- ISBN-13: 9781573317085
- ISBN-10: 157331708X
- Artikelnr.: 22976662
- Verlag: Wiley
- Seitenzahl: 628
- Erscheinungstermin: 1. Januar 2008
- Englisch
- Abmessung: 229mm x 161mm x 25mm
- Gewicht: 1048g
- ISBN-13: 9781573317085
- ISBN-10: 157331708X
- Artikelnr.: 22976662
Natalya E. Seredkina
Ole Petter Rekvig. 2. Type I IFN Inhibition of Inflammatory Th Cell Responses in SLE: Alyson J. Mangini
Robert Lafyatis
Jean Maguire van Seventer. 3. Vascular Elasticity of Systemic Lupus Erythematosis Patients is Associated with Steroids and Hydroxychloroquine Treatment: Amir Tanay
Eyal Leibovitz
Angela Frayman
Rueven Zimlichman
Dov Gavish. 4. Sun-Induced Life-Threatening Lupus Nephritis: Enno Schmidt
Hans-Peter Tony
Eva-Bettina Bröcker
Christian Kneitz. 5. Blood Concentrations of Hydroxychloroquine and its Desethyl Derivative Correlate Negatively with the Percentage of CD45RO+ Cells Among CD4+ Lymphocytes in Hydroxychloroquine Treated Lupus Patients: Laurent Sailler
Bénédicte Puissant
Pascal Méliani
Jean Olivier Castex
Sylvie Saivin
D. Adoue
B. Fournie
Philippe Arlet
Jean-Louis Montastruc
Maryse Laoetyre-Mestre
Jaques Pourrat
Antoine Blancher. 6. Advances in Lupus and Sjögren's Syndrome. A Tribute to Josep Font: Manuel Ramos-Casals
Munther A. Khamashta. 7. Regulatory T Cells and Systemic Lupus Erythematosus: Véronique Parietti
Hélène Chifflot
Sylviane Muller
Fanny Monneaux. 8. Occurrence of Malignancies in Hungarian Patients with Systemic Lupus Erythematosus. Results from a Single Centre: Tünde Tarr
Balázs Gyorfy
Éva Szekanecz
Harjit Pal Bhattoa
Margit Zeher
Gyula Szegedi
Emese Kiss. 9. Reduced Paraoxonase1 Activity is a Risk for Atherosclerosis in Patients with Systemic Lupus Erythematosus: Emese Kiss
Ikdikó Seres
Tünde Tarr
Zsolt Kocsis
Gyula Szegedi
György Paragh. 10. A Potential Trigger of Nephritogenic Anti-DNA Antibodies in Lupus Nephritis: Y. Hirabayashi
Y. Oka
M. Tada
R. Takahashi
T. Ishii. 11. Annexin A5 as a Novel Player in Prevention of Atherithrombosis in SLE and in the General Population: Anna Cederholm
Johan Frostegärd. 12. A Central Role of Nucleosomes in Lupus Nephritis: Kristen A. Fenton
Ole Petter Rekvig. 13. Systemic Lupus Erythematosus: The Face of Asia: Pao-Hsii Feng. 14. Intima-Media Thickness (IMT): A Marker of Accelerated Atherosclerosis in Women with SLE: Barbara Maria Colombo
Giuseppe Murdaca
Matteo Caiti
Guido Rodriguez
Lidia Grassia
Edorado Rossi
Francesco Indiveri
Francesco Puppo. 15. DNA Methylation and Systemic Lupus Erythematosus: Eva Balada
Josep Ordi-Ros
Miguel Vilardell-Tarrés. 16. Antibodies Towards High Density Lipoprotein Components Inhibit Paraoxonase Activity in Patient with Systemic Lupus Erythematosus: J. R. Batuca
P.R.J. Ames
D.A. Issenberg
Alves J. Delgado. 17. Induction of Endothelial Cell Apoptosis by IgG Antibodies from SLE Patients with Nephropathy: A Potential Role for Anti-endothelial-cell-antibodies (AECA): P. van Paassen
A
Duijvestijn
L. Debrus-Palmans
J. Damoiseaux
M. Vroomen
J.W. Cohen Tervaert. 18. Prolactine Effect on Lymphocytes Activation From Systemic Lupus Erythematosus Patients: Chavez-Rueda Karina
Legorreta-Haquet Ma. Victoria
Cervera-Castillo Hernando
Sánchez Lourdes
Jara Luis Javier
Zenteno Edgar
Chavez-Sanchez Luis
Blanco-Favela Francisco. 19. Drug-Induced Lupus: Andrea T. Borchers
Carl L. Keen
M. Eric Gershwin. and Complement Receptors¿20. Altered Expression of Fc on B Cells in Systemic Lupus Erythematosus: Péter Gergely Jr.
Andrea Isaák
Zsuzsanna Szekeres
József Prechl
Anna Erdei
Zsolt B. Nagy
János Gergely
Gyula Poór. 21. Pediatric Systemic Lupus Erythematosus with C1q Deficiency: Maryam Kallel Sellami
Lilia Baili Klila
Yousr Zerzeri
Lillia Laadhar
Jaques Blouin
Mohamed Slim Abdelmoula
Mondher Aitoun
Véronique Fremeaux-Bacchi
Marie France Ben Dridi
Sondes Makni. 22. Hereditary Complement Deficiency and Lupus: Report f 4 Tunisian Cases: Maryam Kallel Sellami
Lilia Baili Klila
Yousr Zerzeri
Lillia Laadhar
Jaques Blouin
Rim Abdelmalek
Véronique Fremeaux-Bacchi
Mondher Zitouni
Sondes Makni. 23. Highly Specific Novel Method for Isolation and Purification of Lupus Anti-DNA Antibody Via Oligo- (DT) Magnetic Beads: Mirjana Pavlovic
Ram Chen
Anna M. Kats
Michelle F. Cavallo
Seth Saccocio
Patricia Keating
James X. Hartmann. 24. Proactin Levels are Associated with Lupus Activity
Lupus Antcoagulant and Poor Outcome in Pregnancy: Luis J. Jara
Heidi Pacheco-Reyes
Gabriela Medina
Ulises Angeles
Polita Cruz-Cruz
Miguel A. Saavedra. 25. Autoantibodies Against Protective Molecules -C1q
C-reactive Protein (CRP)
Serum Amyloid P (SAP)
Mannose-binding Lectin (MBL)
and Apolipoprotein A1 (Apo A1). Prevalence in Systemic Lupus Erythematosus: Yehuda Shoenfeld
Martine-Szyper-Kravitz
Tortsen Witte
Andrea Doria
Akito Tsutsumi
Abe Tatsuya
Jean-Michel Dayer
Pascale Roux-Lombard
Lionel Fontao
Cees G.M. Kallenberg
Marc Bijl
Torsten Mattias
Abigail Fraser
Gisele Zandman-Goddard
Miri Blank
Boris Gilburd
Pier Luigi Meroni. Part II: Scleroderma:. 26. Unstabilized DNA Breaks in Lymphocytes of Patients With Different Subsets of Systemic Sclerosis: Franco Majone
Franco Cozzi
Marta Tonello
Silvia Olivieri
Anna Montaldi
Maria Favari
Serena Visentin
Roberto Luisetto
Amelia Ruffatti. 27. Scleroderna Renal Crisis
Still a Life Threatening Complication:Luis Teixeira
Alfred Mahr
Alice Berezné
Laure-Hélène Noël
Loïc Guillevin
Luc Mouthon. 28. Early Atherosclerosis and Autoantibodies to Heat-Shock Proteins and Oxidized LDL in Systemic Sclerosis: Yaniv Sherar
Marco Matucci Cerinic
Francesca Bartoli
Jelena Blagojevic
Maria Letizia Conforti
Boris Gliburd
Michael Ehrenfeld
Yehuda Shoenfeld. 29. Systemic Sclerosis Associated Myopathy: Brigitte Ranque
Francois-Jérome Authier
Alice Berenze
Loïc Guillevin
Luc Mouthon. 30. Flow Mediated Vasodilation and Carotid Intima-Media Thickness in Systemic Sclerosis: Francesca Bartoli
Jelena Blagojevic
Marzia Bacci
Ginevra Fiori
Alessio Tempestini
MariaLetizia Conforti
Serena Guiducci
Irene Miniati
Mauro Di Chicco
Angela Del Rosso
Federico Perfetto
Sergio Castellani
Alberto Pignone
Marco Matucci Cerinic. 31. Exercise Doppler Echcardiography Identifies Pre-Clinic Asymptomatic Pulmonary Hypertension in Systemic Sclerosis: Alberto Pignone
Fabio Mori
Francesco Pieri
Andrea Oddo
Gianna Galeota
Ginevra Fiori
Angela Del Rosso
Federico Perfetto
Aureliano Becucci
Riccardo Livi
Alessio Tempestini
Chiara Benvenuti
Leonardo Gramigna
Roberto Fedi
Sergio Generini
Martina Minelli
Marina Cinelli
Serena Guiducci
Chiara Arcangeli
Maria Letizia Conforti
Pasquale Bernardo
Marco Matucci Cerinic. 32. Thyroid Dysfunction in Women with Systemic Sclerosis: Bianca Marasini
Pier Alda Ferrari
Nadia Solaro
Carlo Selmi. Part III: Rheumatoid Arthritis:. 33. The Immunology of Rheumatoid Arthritis: Rossana Scrivo
Manuela Di Franco
Antonio Spadaro
Guido Valesini. 34. Citrullination by Peptidyl Arginine Deiminase in Rheumatoid Arthritis: Akari Suzuki
Ryo Yamada
Kazuhiko Yamamoto. 35. Regulation of Cytokine-Induced HIF-1a Expression in Rheumatoid Synovial Fibrolasts: Johanna Westra
Elisabeth Brouwer
Reinhard Bos
Narcek D. Posthumus
Berber Doornbos-van der Meer
Cees G.M. Kallenberg
Piet C. Limburg. 36. Accelerated Atherosclerosis in Rheumatoid Arthritis: Zoltán Szekanecz
György Kerekes
Henriett Dér
Zsuzsa Sándor
Zoltán Szabó
Anikó Végvári
Eniko Simkovics
Lilla Soós
Ágnes Szentpétery
Timea Besenyei
Gabriella Szucs
Sándor Szántó
Gyula Szegedi
Yehuda Shoenfeld
Pál Soltész. 37. Increased Production of the Soluble Tumor-Associated Antigens CA19-9
CA125 and CA15-3 in Rheumatoid Arthritis: Potential Adhesion Molecules in Synovial Inflammation?: Éva Szekanecz
Zsuzsa Sándor
Péter Antal-Szalmás
Lilla Soós
Gabriella Lakos
Timea Besenyei
Ágnes Szentpétery
Eniko Simkovics
János Szántó
Emese Kiss
Alisa E. Koch
Zoltán Szekanecz. 38. Precocious Atherosclerosis in Rheumatoid Arthritis: Role of Traditional and Disease-Related Cardiovascular Risk Factors: Roberto Gerli
Yaniv Sherar
Elena Bartoloni Bocci
Gaetano Vaudo
Sheila Moscatelli
Yehuda Shoenfeld. 39. A New Target for Autoantibodies in Patients with Rheumatoid Arthritis: Magali Robert-Pachot
Agnes Desbos
Annick Moreiera
Michel Becchi
Jacques Tebib
Michel Bonnin
Tarik Aitsiselmi
Jacques Bienvenu
Nicole Fabien. 40. Preclinical Impairment of Coronary Flow Reserve in Patients with Rheumatoid Arthritis: Fabiola Atzeni
Piercarlo Sarzi-Puttini
Giuseppe De Blasio
Luigi Delfino
Livio Tomasoni
Maurizio Turiel. 41. Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments: G. Morozzi
M. Fabbroni
F. Bellisai
G. Pucci
M. Galeazzi. 42. Heat-Shock Protein 65 Autoantibodies Are Differently Associated with Early Atherosclerosis in Rheumatoid Arthritis and in Healthy Subjects: Yaniv Sherer
Roberto Gerli
Elena Bartoloni Bocci
Boris Gilburd
Gaetano Vaudo
Onelia Bistoni
Yehuda Shoenfeld. Part IV: Sjogren's Syndrome:. 43. Antibodies Against Alpha-Fodrin are Associated with Sicca Syndrome in the General Population: Torsten Witte
Torsten Matthias
Janine Bierwirth
Reinhold E. Schmidt. 44. Autoantibodies from Sjögren's Syndrome Trigger Apoptosis in Salivary Gland Cell Line:Y. Margherita Sisto
Sabrina Lisi
Dario Lofrumento
Massimo D' Amore. Pasquale Scagliusi
Vincenzo Mitolo. 45. The Influence of Sex Steroids on Sjögren's Syndrome: Pauliina Porola
Mikael Laine
Liisa Virkki
Praseet Poduval
Yrjö Konttinen. 46. Sjögren's Syndrome - A Plethora of Clinical and Immunological Phenotypes with a Complex Genetic Background. By Roland Jonsson
Anne Isine Bolstad
Karl A. Brokstad
Johan G. Brun. Part V: Antiphospholipid Antibodies:. 47. Catastrophic Antiphospholipid Syndrome: Lessons from the "Caps Registry" - A Tribute to the Late Josep Font:Richard Cervera
Silvia Bucciarelli
Gerard Espinosa
José A. Gómez-Puerta
Manuel Ramos-Casals
Yehuda Shoenfeld
Jean-Charles Piette
Ronald A. Asherson. 48. Antigenic Profile
Prevalence and Clinical Significance of Antiphospholipid Antibodies in Women Referred for Invitro Fertilization. By M. Sanmarco
N. Bardin
L. Camoin
A. Beziane
F. Dignat-George
M. Gamerre
G. Porcu. 49. Antiphospholipid Antibodies in Patients with Coronary Artery Disease: New Cardiac Risk Factors: Tom P. Greco
Ann Marie Conti-Kelly
Eiji Matsuura
Tom Greco Jr.
Ken J. Dier
Gregory Svanas
Robin Doyle
Luis R. Lopez. 50. Subclinical Atherosclerosis in Primary Antiphospholipid Syndrome: Annamariea Margarita
Joana Batuca
Giovanna Scebba
Jose' Delgado Alves
Louis Lopez
Luigi Iannaccine
Eiji Matsuura
Paul R.J. Ames. 51. Cross-reactive Epitopes on b2-Glycoprotein-I and Saccharomyces Cerevisiae in Patients with the Antiphospholipid Syndrome: I. Krause
M. Blank
R. Cervera
J. Font
T. Matthias
S. Pfeiffer
I. Wies
A. Fraser
Yehuda Shoenfeld. 52. Atherogenic Antiphospholipid Antibodies in Antiphospholipid Syndrome: Kazuko Kobayashi
Luis R. Lopez
Eiji Matsuura. 53. A Novel Overlap Syndrome: Systemic Sclerosis Associated with Antiphospholipid Syndrome - A Case Series: Gisele Zandman-Goddard
Nurit Tweezer-Zaks
Tamar Shalev
Yair Levy
Michael Ehrenfeld
Pnina Langevitz. 54. Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid Antibodies. A Review of the Literature: Nicoletta Di Simone
Pier Luigi Meroni
Marco D'Asta
Fiorella Di Nicuolo
Silvia D'Ippoloto
Maria Clara D'Alessio
Alessandro Caruso. 55. Peripheral Vascular Occlusions Leading to Gangrene and Amputations in Antiphospholipid Antibody Positive Patients: Ronald A. Asherson
Yehuda Shoenfeld. 56. Uterine Artery Velocity Waveforms as Predictors of Pregnancy Outcome in Patients with Antiphospholipid Syndrome (APS): A Review: Sara De Carolis
Angela Botta
Serafina Garofalo
Sergio Ferrazzani
Carmelinda Martino
Gabriella Fatigante
Leonardo Caforio
Alessandro Caruso. 57. In Vivo Effects of An Inhibitor of Nuclear Factor-Kappa (k) B On Thrombogenic Properties of Antiphospholipid Antibodies: Guadalupe Montiel Manzano
Zurina Romay-Penabad
Elizabeth Papalardo de Martinez
L.A. Meillon-Garcia
E. Garcia-Lattore
E. Reyes-Maldonado
Silvia S. Pierangeli. 58. C5a Receptor Deficient Mice Are Protected From Thrombophilia and Endothelial Cell Activation Induced By Some Antiphospholipid Antibodies: Zurina Romay-Penabad
Xiaowei Liu X
Guadalupe Montiel-Manzano
Elizabeth Papalardo de Martinez
Silvia S. Pierangeli. Part VI: Infections and Autoantibodies:. 59. EBV and CMV in Autoimmune Diseases: Are They Truly Notorious? A Preliminary Report: O. Barzilai
Y. Sherer
D. Izhaky
Yehuda Shoenfeld. 60. Are Antiphospholipid Antibodies An Essential Requirement for an Effective Immune Response to Infections?: Philipp von Landenberg
Yvonne Döring
Susanne Modrow
Karl J. Lackner. 61. Autoantibodies in Non-Autoimmune Individuals During Infections: Tatiana Berlin
Gisele Zandman-Goddard
Miri Blank
Torsten Matthias
Sascha Pfeiffer
Ingrid Weis
Elias Toubi
Sham Singh
Ronald Asherson
Abigail Fraser
Boris Gilburd
Tal Sapir
Yair Levy
Janja Likac
Blaz Rozman
Tanja Kveder
Yehuda Shoenfeld. 62. Chronic Infections and Atherosclerosis: Kiyoshi Ayada
Kenji Yokota
Kazuko Kobayashi
Yehuda Shoenfeld
Eiji Matsuura
Keiji Oguma. 63. Chronic Idiopathic Granulomatous Mastitis: Uriel Katz
Yair Molad
Jacob Ablin
Debby Ben-David
Daphna Paran
Mordechai Gutman
Pnina Langevitz
Natalya E. Seredkina
Ole Petter Rekvig. 2. Type I IFN Inhibition of Inflammatory Th Cell Responses in SLE: Alyson J. Mangini
Robert Lafyatis
Jean Maguire van Seventer. 3. Vascular Elasticity of Systemic Lupus Erythematosis Patients is Associated with Steroids and Hydroxychloroquine Treatment: Amir Tanay
Eyal Leibovitz
Angela Frayman
Rueven Zimlichman
Dov Gavish. 4. Sun-Induced Life-Threatening Lupus Nephritis: Enno Schmidt
Hans-Peter Tony
Eva-Bettina Bröcker
Christian Kneitz. 5. Blood Concentrations of Hydroxychloroquine and its Desethyl Derivative Correlate Negatively with the Percentage of CD45RO+ Cells Among CD4+ Lymphocytes in Hydroxychloroquine Treated Lupus Patients: Laurent Sailler
Bénédicte Puissant
Pascal Méliani
Jean Olivier Castex
Sylvie Saivin
D. Adoue
B. Fournie
Philippe Arlet
Jean-Louis Montastruc
Maryse Laoetyre-Mestre
Jaques Pourrat
Antoine Blancher. 6. Advances in Lupus and Sjögren's Syndrome. A Tribute to Josep Font: Manuel Ramos-Casals
Munther A. Khamashta. 7. Regulatory T Cells and Systemic Lupus Erythematosus: Véronique Parietti
Hélène Chifflot
Sylviane Muller
Fanny Monneaux. 8. Occurrence of Malignancies in Hungarian Patients with Systemic Lupus Erythematosus. Results from a Single Centre: Tünde Tarr
Balázs Gyorfy
Éva Szekanecz
Harjit Pal Bhattoa
Margit Zeher
Gyula Szegedi
Emese Kiss. 9. Reduced Paraoxonase1 Activity is a Risk for Atherosclerosis in Patients with Systemic Lupus Erythematosus: Emese Kiss
Ikdikó Seres
Tünde Tarr
Zsolt Kocsis
Gyula Szegedi
György Paragh. 10. A Potential Trigger of Nephritogenic Anti-DNA Antibodies in Lupus Nephritis: Y. Hirabayashi
Y. Oka
M. Tada
R. Takahashi
T. Ishii. 11. Annexin A5 as a Novel Player in Prevention of Atherithrombosis in SLE and in the General Population: Anna Cederholm
Johan Frostegärd. 12. A Central Role of Nucleosomes in Lupus Nephritis: Kristen A. Fenton
Ole Petter Rekvig. 13. Systemic Lupus Erythematosus: The Face of Asia: Pao-Hsii Feng. 14. Intima-Media Thickness (IMT): A Marker of Accelerated Atherosclerosis in Women with SLE: Barbara Maria Colombo
Giuseppe Murdaca
Matteo Caiti
Guido Rodriguez
Lidia Grassia
Edorado Rossi
Francesco Indiveri
Francesco Puppo. 15. DNA Methylation and Systemic Lupus Erythematosus: Eva Balada
Josep Ordi-Ros
Miguel Vilardell-Tarrés. 16. Antibodies Towards High Density Lipoprotein Components Inhibit Paraoxonase Activity in Patient with Systemic Lupus Erythematosus: J. R. Batuca
P.R.J. Ames
D.A. Issenberg
Alves J. Delgado. 17. Induction of Endothelial Cell Apoptosis by IgG Antibodies from SLE Patients with Nephropathy: A Potential Role for Anti-endothelial-cell-antibodies (AECA): P. van Paassen
A
Duijvestijn
L. Debrus-Palmans
J. Damoiseaux
M. Vroomen
J.W. Cohen Tervaert. 18. Prolactine Effect on Lymphocytes Activation From Systemic Lupus Erythematosus Patients: Chavez-Rueda Karina
Legorreta-Haquet Ma. Victoria
Cervera-Castillo Hernando
Sánchez Lourdes
Jara Luis Javier
Zenteno Edgar
Chavez-Sanchez Luis
Blanco-Favela Francisco. 19. Drug-Induced Lupus: Andrea T. Borchers
Carl L. Keen
M. Eric Gershwin. and Complement Receptors¿20. Altered Expression of Fc on B Cells in Systemic Lupus Erythematosus: Péter Gergely Jr.
Andrea Isaák
Zsuzsanna Szekeres
József Prechl
Anna Erdei
Zsolt B. Nagy
János Gergely
Gyula Poór. 21. Pediatric Systemic Lupus Erythematosus with C1q Deficiency: Maryam Kallel Sellami
Lilia Baili Klila
Yousr Zerzeri
Lillia Laadhar
Jaques Blouin
Mohamed Slim Abdelmoula
Mondher Aitoun
Véronique Fremeaux-Bacchi
Marie France Ben Dridi
Sondes Makni. 22. Hereditary Complement Deficiency and Lupus: Report f 4 Tunisian Cases: Maryam Kallel Sellami
Lilia Baili Klila
Yousr Zerzeri
Lillia Laadhar
Jaques Blouin
Rim Abdelmalek
Véronique Fremeaux-Bacchi
Mondher Zitouni
Sondes Makni. 23. Highly Specific Novel Method for Isolation and Purification of Lupus Anti-DNA Antibody Via Oligo- (DT) Magnetic Beads: Mirjana Pavlovic
Ram Chen
Anna M. Kats
Michelle F. Cavallo
Seth Saccocio
Patricia Keating
James X. Hartmann. 24. Proactin Levels are Associated with Lupus Activity
Lupus Antcoagulant and Poor Outcome in Pregnancy: Luis J. Jara
Heidi Pacheco-Reyes
Gabriela Medina
Ulises Angeles
Polita Cruz-Cruz
Miguel A. Saavedra. 25. Autoantibodies Against Protective Molecules -C1q
C-reactive Protein (CRP)
Serum Amyloid P (SAP)
Mannose-binding Lectin (MBL)
and Apolipoprotein A1 (Apo A1). Prevalence in Systemic Lupus Erythematosus: Yehuda Shoenfeld
Martine-Szyper-Kravitz
Tortsen Witte
Andrea Doria
Akito Tsutsumi
Abe Tatsuya
Jean-Michel Dayer
Pascale Roux-Lombard
Lionel Fontao
Cees G.M. Kallenberg
Marc Bijl
Torsten Mattias
Abigail Fraser
Gisele Zandman-Goddard
Miri Blank
Boris Gilburd
Pier Luigi Meroni. Part II: Scleroderma:. 26. Unstabilized DNA Breaks in Lymphocytes of Patients With Different Subsets of Systemic Sclerosis: Franco Majone
Franco Cozzi
Marta Tonello
Silvia Olivieri
Anna Montaldi
Maria Favari
Serena Visentin
Roberto Luisetto
Amelia Ruffatti. 27. Scleroderna Renal Crisis
Still a Life Threatening Complication:Luis Teixeira
Alfred Mahr
Alice Berezné
Laure-Hélène Noël
Loïc Guillevin
Luc Mouthon. 28. Early Atherosclerosis and Autoantibodies to Heat-Shock Proteins and Oxidized LDL in Systemic Sclerosis: Yaniv Sherar
Marco Matucci Cerinic
Francesca Bartoli
Jelena Blagojevic
Maria Letizia Conforti
Boris Gliburd
Michael Ehrenfeld
Yehuda Shoenfeld. 29. Systemic Sclerosis Associated Myopathy: Brigitte Ranque
Francois-Jérome Authier
Alice Berenze
Loïc Guillevin
Luc Mouthon. 30. Flow Mediated Vasodilation and Carotid Intima-Media Thickness in Systemic Sclerosis: Francesca Bartoli
Jelena Blagojevic
Marzia Bacci
Ginevra Fiori
Alessio Tempestini
MariaLetizia Conforti
Serena Guiducci
Irene Miniati
Mauro Di Chicco
Angela Del Rosso
Federico Perfetto
Sergio Castellani
Alberto Pignone
Marco Matucci Cerinic. 31. Exercise Doppler Echcardiography Identifies Pre-Clinic Asymptomatic Pulmonary Hypertension in Systemic Sclerosis: Alberto Pignone
Fabio Mori
Francesco Pieri
Andrea Oddo
Gianna Galeota
Ginevra Fiori
Angela Del Rosso
Federico Perfetto
Aureliano Becucci
Riccardo Livi
Alessio Tempestini
Chiara Benvenuti
Leonardo Gramigna
Roberto Fedi
Sergio Generini
Martina Minelli
Marina Cinelli
Serena Guiducci
Chiara Arcangeli
Maria Letizia Conforti
Pasquale Bernardo
Marco Matucci Cerinic. 32. Thyroid Dysfunction in Women with Systemic Sclerosis: Bianca Marasini
Pier Alda Ferrari
Nadia Solaro
Carlo Selmi. Part III: Rheumatoid Arthritis:. 33. The Immunology of Rheumatoid Arthritis: Rossana Scrivo
Manuela Di Franco
Antonio Spadaro
Guido Valesini. 34. Citrullination by Peptidyl Arginine Deiminase in Rheumatoid Arthritis: Akari Suzuki
Ryo Yamada
Kazuhiko Yamamoto. 35. Regulation of Cytokine-Induced HIF-1a Expression in Rheumatoid Synovial Fibrolasts: Johanna Westra
Elisabeth Brouwer
Reinhard Bos
Narcek D. Posthumus
Berber Doornbos-van der Meer
Cees G.M. Kallenberg
Piet C. Limburg. 36. Accelerated Atherosclerosis in Rheumatoid Arthritis: Zoltán Szekanecz
György Kerekes
Henriett Dér
Zsuzsa Sándor
Zoltán Szabó
Anikó Végvári
Eniko Simkovics
Lilla Soós
Ágnes Szentpétery
Timea Besenyei
Gabriella Szucs
Sándor Szántó
Gyula Szegedi
Yehuda Shoenfeld
Pál Soltész. 37. Increased Production of the Soluble Tumor-Associated Antigens CA19-9
CA125 and CA15-3 in Rheumatoid Arthritis: Potential Adhesion Molecules in Synovial Inflammation?: Éva Szekanecz
Zsuzsa Sándor
Péter Antal-Szalmás
Lilla Soós
Gabriella Lakos
Timea Besenyei
Ágnes Szentpétery
Eniko Simkovics
János Szántó
Emese Kiss
Alisa E. Koch
Zoltán Szekanecz. 38. Precocious Atherosclerosis in Rheumatoid Arthritis: Role of Traditional and Disease-Related Cardiovascular Risk Factors: Roberto Gerli
Yaniv Sherar
Elena Bartoloni Bocci
Gaetano Vaudo
Sheila Moscatelli
Yehuda Shoenfeld. 39. A New Target for Autoantibodies in Patients with Rheumatoid Arthritis: Magali Robert-Pachot
Agnes Desbos
Annick Moreiera
Michel Becchi
Jacques Tebib
Michel Bonnin
Tarik Aitsiselmi
Jacques Bienvenu
Nicole Fabien. 40. Preclinical Impairment of Coronary Flow Reserve in Patients with Rheumatoid Arthritis: Fabiola Atzeni
Piercarlo Sarzi-Puttini
Giuseppe De Blasio
Luigi Delfino
Livio Tomasoni
Maurizio Turiel. 41. Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments: G. Morozzi
M. Fabbroni
F. Bellisai
G. Pucci
M. Galeazzi. 42. Heat-Shock Protein 65 Autoantibodies Are Differently Associated with Early Atherosclerosis in Rheumatoid Arthritis and in Healthy Subjects: Yaniv Sherer
Roberto Gerli
Elena Bartoloni Bocci
Boris Gilburd
Gaetano Vaudo
Onelia Bistoni
Yehuda Shoenfeld. Part IV: Sjogren's Syndrome:. 43. Antibodies Against Alpha-Fodrin are Associated with Sicca Syndrome in the General Population: Torsten Witte
Torsten Matthias
Janine Bierwirth
Reinhold E. Schmidt. 44. Autoantibodies from Sjögren's Syndrome Trigger Apoptosis in Salivary Gland Cell Line:Y. Margherita Sisto
Sabrina Lisi
Dario Lofrumento
Massimo D' Amore. Pasquale Scagliusi
Vincenzo Mitolo. 45. The Influence of Sex Steroids on Sjögren's Syndrome: Pauliina Porola
Mikael Laine
Liisa Virkki
Praseet Poduval
Yrjö Konttinen. 46. Sjögren's Syndrome - A Plethora of Clinical and Immunological Phenotypes with a Complex Genetic Background. By Roland Jonsson
Anne Isine Bolstad
Karl A. Brokstad
Johan G. Brun. Part V: Antiphospholipid Antibodies:. 47. Catastrophic Antiphospholipid Syndrome: Lessons from the "Caps Registry" - A Tribute to the Late Josep Font:Richard Cervera
Silvia Bucciarelli
Gerard Espinosa
José A. Gómez-Puerta
Manuel Ramos-Casals
Yehuda Shoenfeld
Jean-Charles Piette
Ronald A. Asherson. 48. Antigenic Profile
Prevalence and Clinical Significance of Antiphospholipid Antibodies in Women Referred for Invitro Fertilization. By M. Sanmarco
N. Bardin
L. Camoin
A. Beziane
F. Dignat-George
M. Gamerre
G. Porcu. 49. Antiphospholipid Antibodies in Patients with Coronary Artery Disease: New Cardiac Risk Factors: Tom P. Greco
Ann Marie Conti-Kelly
Eiji Matsuura
Tom Greco Jr.
Ken J. Dier
Gregory Svanas
Robin Doyle
Luis R. Lopez. 50. Subclinical Atherosclerosis in Primary Antiphospholipid Syndrome: Annamariea Margarita
Joana Batuca
Giovanna Scebba
Jose' Delgado Alves
Louis Lopez
Luigi Iannaccine
Eiji Matsuura
Paul R.J. Ames. 51. Cross-reactive Epitopes on b2-Glycoprotein-I and Saccharomyces Cerevisiae in Patients with the Antiphospholipid Syndrome: I. Krause
M. Blank
R. Cervera
J. Font
T. Matthias
S. Pfeiffer
I. Wies
A. Fraser
Yehuda Shoenfeld. 52. Atherogenic Antiphospholipid Antibodies in Antiphospholipid Syndrome: Kazuko Kobayashi
Luis R. Lopez
Eiji Matsuura. 53. A Novel Overlap Syndrome: Systemic Sclerosis Associated with Antiphospholipid Syndrome - A Case Series: Gisele Zandman-Goddard
Nurit Tweezer-Zaks
Tamar Shalev
Yair Levy
Michael Ehrenfeld
Pnina Langevitz. 54. Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid Antibodies. A Review of the Literature: Nicoletta Di Simone
Pier Luigi Meroni
Marco D'Asta
Fiorella Di Nicuolo
Silvia D'Ippoloto
Maria Clara D'Alessio
Alessandro Caruso. 55. Peripheral Vascular Occlusions Leading to Gangrene and Amputations in Antiphospholipid Antibody Positive Patients: Ronald A. Asherson
Yehuda Shoenfeld. 56. Uterine Artery Velocity Waveforms as Predictors of Pregnancy Outcome in Patients with Antiphospholipid Syndrome (APS): A Review: Sara De Carolis
Angela Botta
Serafina Garofalo
Sergio Ferrazzani
Carmelinda Martino
Gabriella Fatigante
Leonardo Caforio
Alessandro Caruso. 57. In Vivo Effects of An Inhibitor of Nuclear Factor-Kappa (k) B On Thrombogenic Properties of Antiphospholipid Antibodies: Guadalupe Montiel Manzano
Zurina Romay-Penabad
Elizabeth Papalardo de Martinez
L.A. Meillon-Garcia
E. Garcia-Lattore
E. Reyes-Maldonado
Silvia S. Pierangeli. 58. C5a Receptor Deficient Mice Are Protected From Thrombophilia and Endothelial Cell Activation Induced By Some Antiphospholipid Antibodies: Zurina Romay-Penabad
Xiaowei Liu X
Guadalupe Montiel-Manzano
Elizabeth Papalardo de Martinez
Silvia S. Pierangeli. Part VI: Infections and Autoantibodies:. 59. EBV and CMV in Autoimmune Diseases: Are They Truly Notorious? A Preliminary Report: O. Barzilai
Y. Sherer
D. Izhaky
Yehuda Shoenfeld. 60. Are Antiphospholipid Antibodies An Essential Requirement for an Effective Immune Response to Infections?: Philipp von Landenberg
Yvonne Döring
Susanne Modrow
Karl J. Lackner. 61. Autoantibodies in Non-Autoimmune Individuals During Infections: Tatiana Berlin
Gisele Zandman-Goddard
Miri Blank
Torsten Matthias
Sascha Pfeiffer
Ingrid Weis
Elias Toubi
Sham Singh
Ronald Asherson
Abigail Fraser
Boris Gilburd
Tal Sapir
Yair Levy
Janja Likac
Blaz Rozman
Tanja Kveder
Yehuda Shoenfeld. 62. Chronic Infections and Atherosclerosis: Kiyoshi Ayada
Kenji Yokota
Kazuko Kobayashi
Yehuda Shoenfeld
Eiji Matsuura
Keiji Oguma. 63. Chronic Idiopathic Granulomatous Mastitis: Uriel Katz
Yair Molad
Jacob Ablin
Debby Ben-David
Daphna Paran
Mordechai Gutman
Pnina Langevitz